P682: nemtabrutinib (mk-1026), a non-covalent inhibitor of wild-type and c481s mutated bruton tyrosine kinase for b-cell malignancies: efficacy and safety of the phase 2 dose-expansion bellwave-001 study
HemaSphere（2022）
关键词
bruton tyrosine kinase,malignancies,nemtabrutinib,non-covalent,wild-type,b-cell,dose-expansion
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要